The inhaler, with an older propellant, is already approved in Europe for the treatment of adults with chronic obstructive ...

Regeneron Pharmaceuticals will release its second-quarter earnings next month, and analysts anticipate a double-digit profit ...

In recently reported case studies, nemolizumab, approved for two indications associated with itch, has been reported to be ...

Shares of Regeneron Pharmaceuticals Inc. REGN slid 1.35% to $564.64 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.07% to ...

Suffolk, one of the most innovative and successful builders in the country, is expanding its California footprint with the ...

In this Healio Video Perspective from the ARVO meeting, Michael Javaheri, MD, overviews real-world data on Eylea HD in ...

The FDA approved Anzupgo for the treatment of moderate to severe chronic hand eczema in adults who do not adequately respond ...

The CHMP’s recommendation will be reviewed by the European Commission (EC), which is expected to make its final decision soon. Pfizer and BioNTech have already initiated manufacturing of the ...

Sanofi's wide lineup of branded drugs and vaccines and robust pipeline create strong cash flows and a narrow economic moat. Growth of existing products and new product launches should help offset ...

Hodgkin's lymphoma market size is expected to increase during the forecast period (2025–2034) owing to increasing incidence, advancements in ...

Meet 12 biotech companies with promising genetic disease therapies that successfully closed funding rounds recently.

Pranet Khetan has developed Paraspeak, an AI-powered device that converts slurred Hindi speech into clear audio for patients ...